A Study of Two Doses of 18F-AV-45 in Alzheimer's Disease and Healthy Volunteers

Completed · Phase 1

Conditions studied: Alzheimer Disease

In brief

This study will test two different doses of florbetapir F 18 to determine which dose is best to image amyloid plaques in the brains of Alzheimer's Disease (AD) patients using a positron emission tomography (PET) scanner.

Key facts

Study ID

NCT01565330

Run by

Avid Radiopharmaceuticals

People needed

20

Starts

2008-03-01

Expected to finish

2008-08-01

Last updated by the study team

2012-06-18

Who can join

Age: 35 and older. Sex: any. Healthy volunteers: accepted.

Where it is running

• Research Site — West Palm Beach, Florida, United States
• Research Site — North East, Maryland, United States
• Research Site — Clementon, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.